Zobrazeno 1 - 10
of 3 429
pro vyhledávání: '"zoster vaccine"'
Autor:
Tsai Y; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.. Electronic address: ytsai@cdc.gov., Leung J; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Anderson TC; Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Zhou F; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA., Singleton JA; Immunization Services Division, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA.
Publikováno v:
Vaccine [Vaccine] 2025 Jan 01; Vol. 43 (Pt 1), pp. 126537. Date of Electronic Publication: 2024 Nov 22.
Autor:
Pang X; Department of Immunization, CDC, Beijing, China., Spence O; GSK, Rockville, USA., Parmar N; GSK, Bengaluru, India., Wang J; GSK, Rockville, USA., Zhou T; Department of Immunization, CDC, Beijing, China., Guo X; Department of Immunization, CDC, Shanghai, China., Colliou A; GSK, Wavre, Belgium., Pradeep Sarang S; GSK, Bengaluru, India., Yousefi M; GSK, Rockville, USA., Yun H; GSK, Rockville, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2439031. Date of Electronic Publication: 2024 Dec 16.
Autor:
Alexandra Echeverria Proano D; GSK, Wavre, Belgium., Zhu F; Department of Acute Infectious Disease Control and Prevention, Jiangsu Province Center for Disease Control and Prevention, Nanjing, China., Sun X; Department of Immunization Program, Shanghai Municipal Center for Disease Control and Prevention, Shanghai, China., Zoco J; GSK, Wavre, Belgium., Soni J; GSK, Wavre, Belgium., Parmar N; GSK, Bangalore, India., Ali SO; GSK, Rockville, MD, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2351584. Date of Electronic Publication: 2024 Jun 05.
Autor:
Oh H; Department of Infectious Diseases, Changi General Hospital, Singapore, Singapore., Tan C; The Good Life Medical Centre, Geriatric Medicine, Mount Alvernia Hospital, Singapore, Singapore., Williams C; Medical Affairs, GSK, Wavre, Belgium., Giannelos N; VEO Vaccines, GSK, Wavre, Belgium., Ng C; VEO Greater China and Intercontinental, GSK, Singapore, Singapore.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2348839. Date of Electronic Publication: 2024 May 28.
Autor:
García A; Market Access, GSK, Madrid, Spain., Vallejo-Aparicio LA; Market Access, GSK, Madrid, Spain., Cambronero Martinez R; Market Access, GSK, Madrid, Spain.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2366353. Date of Electronic Publication: 2024 Jun 26.
Autor:
Hung CT; School of Pharmacy, College of Pharmacy, Taipei Medical University, Taipei, Taiwan. Electronic address: b323106029@tmu.edu.tw., Wang LM; Department of Pharmacy, Taipei Medical University Hospital, Taipei, Taiwan., Hung YC; School of Medicine, College of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Publikováno v:
Vaccine [Vaccine] 2025 Jan 01; Vol. 43 (Pt 2), pp. 126523. Date of Electronic Publication: 2024 Nov 18.
Autor:
Lobo-Chan AM; From the University of Illinois at Chicago, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA. Electronic address: alobo2@uic.edu., Song A; From the University of Illinois at Chicago, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA., Kadakia A; From the University of Illinois at Chicago, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA., Mehta SD; From the University of Illinois at Chicago, Illinois Eye and Ear Infirmary, Chicago, Illinois, USA.
Publikováno v:
American journal of ophthalmology [Am J Ophthalmol] 2025 Jan; Vol. 269, pp. 435-449. Date of Electronic Publication: 2024 Oct 01.
Autor:
Carta V; Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy., Mangeri L; Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna, Brescia, Italy., Tiecco G; Department of Clinical and Experimental Sciences, University of Brescia-ASST Spedali Civili, Brescia, Italy., Focà E; Department of Clinical and Experimental Sciences, University of Brescia-ASST Spedali Civili, Brescia, Italy., Quiros-Roldan E; Department of Clinical and Experimental Sciences, University of Brescia-ASST Spedali Civili, Brescia, Italy., De Francesco MA; Department of Molecular and Translational Medicine, Institute of Microbiology, University of Brescia-ASST Spedali Civili, Brescia, Italy.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2341456. Date of Electronic Publication: 2024 Apr 22.
Autor:
Florea A; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Sy L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Qian L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Ackerson B; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Luo Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Wu J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Cheng Y; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Ku J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Vega Daily L; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Takhar H; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Song J; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA., Chmielewski-Yee E; Department of Epidemiology and Patient-Centered Outcomes, GSK, Rockville, MD, USA., Spence O; Department of Epidemiology and Patient-Centered Outcomes, GSK, Rockville, MD, USA., Seifert H; Department of Clinical Safety and Pharmacovigilance, GSK, Rockville, MD, USA., Oraichi D; Department of Real World Analytics, GSK, Rockville, MD, USA., Tseng HF; Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, CA, USA.; Department of Health Systems Science, Kaiser Permanente Bernard J. Tyson School of Medicine, Pasadena, CA, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2327145. Date of Electronic Publication: 2024 Mar 15.
Autor:
Srikanth P; Department of Microbiology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India., Arumugam I; Department of Microbiology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India., Jeganathan SN; Department of Microbiology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India., Ramesh R; Department of Neurology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India., Ranganathan LN; Department of Neurology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India., Vijayaraghavan S; Department of Hepatology and Medical Gastroenterology, Sri Ramachandra Medical College and Research Institute (SRIHER, DU), Chennai, India.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2024 Dec 31; Vol. 20 (1), pp. 2328955. Date of Electronic Publication: 2024 Mar 22.